GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » EV-to-EBITDA

Smruthi Organics (BOM:540686) EV-to-EBITDA : 16.96 (As of Jun. 17, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Smruthi Organics's enterprise value is ₹2,040 Mil. Smruthi Organics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹120 Mil. Therefore, Smruthi Organics's EV-to-EBITDA for today is 16.96.

The historical rank and industry rank for Smruthi Organics's EV-to-EBITDA or its related term are showing as below:

BOM:540686' s EV-to-EBITDA Range Over the Past 10 Years
Min: -160.99   Med: 8.69   Max: 39.2
Current: 16.96

During the past 13 years, the highest EV-to-EBITDA of Smruthi Organics was 39.20. The lowest was -160.99. And the median was 8.69.

BOM:540686's EV-to-EBITDA is ranked worse than
59.21% of 711 companies
in the Drug Manufacturers industry
Industry Median: 14.44 vs BOM:540686: 16.96

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-17), Smruthi Organics's stock price is ₹168.55. Smruthi Organics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3.140. Therefore, Smruthi Organics's PE Ratio for today is 53.68.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Smruthi Organics EV-to-EBITDA Historical Data

The historical data trend for Smruthi Organics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics EV-to-EBITDA Chart

Smruthi Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.08 8.68 13.98 15.27 14.82

Smruthi Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.27 11.24 17.12 19.50 14.82

Competitive Comparison of Smruthi Organics's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smruthi Organics's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's EV-to-EBITDA falls into.



Smruthi Organics EV-to-EBITDA Calculation

Smruthi Organics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2040.009/120.31
=16.96

Smruthi Organics's current Enterprise Value is ₹2,040 Mil.
Smruthi Organics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smruthi Organics  (BOM:540686) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Smruthi Organics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=168.55/3.140
=53.68

Smruthi Organics's share price for today is ₹168.55.
Smruthi Organics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3.140.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Smruthi Organics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Smruthi Organics (BOM:540686) Business Description

Traded in Other Exchanges
N/A
Address
165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines